Low-dose quadruple therapy promising for hypertension management
The mixed-methods process evaluation of the Quadruple Ultra‐Low‐Dose Treatment for Hypertension USA (QUARTET USA) clinical trial examines the perceptions of patients and healthcare professionals on the use of low-dose quadruple therapy (LDQT) as a novel approach for managing hypertension. A study published in the Journal of the American Heart Association, JAHA, has concluded that LDQT […]